This Study Aims to Explore the Efficacy of Hyperbaric Oxygen in the Treatment of Flap Ischaemic Necrosis After Breast Cancer Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-60
SponsorGuangdong Provincial People's Hospital

About this trial

The expectation of our study was to explore the efficacy of using hyperbaric oxygen to rescue flap ischaemic necrosis after breast cancer surgery.

Eligibility criteria

Qualifiers

understand the study procedure, participate in the study voluntarily and sign the informed consent form

aged ≥ 18 years and ≤ 60 years, female

ECOG 0-2

patients with The SKIN Score Degree of B-D and The SKIN area of 1-3 in the Clavien-Dindo classification after breast cancer surgery;

Disqualifiers

Contraindications to hyperbaric oxygen therapy: lung disease (severe chronic obstructive airway disease, herpetic lung disease, acute or chronic lung infection, uncontrolled asthma, untreated pneumothorax), history of previous middle ear surgery, middle ear disease (Eustachian tube dysfunction, recurrent episodes of vertigo), eye disease (retinal detachment).

Pregnancy or lactation.

any other condition that the investigators think the patient is unsuitable for participation in the study

Trial design

Treatments tested in this trial

  • hyperbaric oxygen therapy and povidone-iodine wet compresses
  • wet compresses of povidone-iodine

Treatment groups

76 Participants
are divided into 2 treatment groups